On June 6, 2023, Barry Sytner, the sole Director and Chief Executive Officer of Yijia Group Corp., entered into a securities purchase agreement with Xianchang Ma (“Mr. Ma”), pursuant to which Mr. Sytner sold 5,066,250 shares of common stock of the Company to Mr. Ma, constituting approximately 86.3% of the issued and outstanding shares of the Company as of May 2, 2023, for a total consideration of $470,562, derived from the purchaser’s personal funds. The Securities Purchase Agreement was closed on June 14, 2023. Following the closing, Mr. Ma acquired a beneficial interest in 5,066,250 shares of common stock of the Company constituting approximately 86.3% of the issued and outstanding shares of the Company as of May 2, 2023 and constituting control of the Company.

On June 14, 2023, the sole Director of the Company, Mr. Sytner, resolved to step down from his positions as President and Director of the Company, and for Mr. Xianchang Ma to be appointed as President and Director of the Company. Xianchang Ma, age 48, established a company named Jinan Tengiun Biological Technology Co. Ltd. in 2014.

Mr. Ma is the Chief Executive Officer, Chief Financial Officer and Director of Tengjun Biotechnology Corp. Over the years, Mr. Ma has devoted himself to enterprise management and has abundant corporate management experience. In 2015, he returned to the county of Jinxiang and founded Kanglong.

On November 22, 2011, he established the company named Jinan Kanglong Environmental Protection Technology Co. Ltd. From 2009 to 2011, Mr. Ma served as Marketing and Sales Director of Shijiazhuang Shikang Fuchang Technology Co. Ltd. From 2007 to 2009, he was the sales clerk of Shenzhen Rongge Company.

From 1994 to 2007, Mr. Ma was self-employed.